Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

    ... of normal unless attributable to underlying disease, hemolysis or documented Gilbert’s syndrome. AST (SGOT)/ALT (SGPT) < ...

    Clinical Trial last updated 05/14/2018 - 2:02pm.

  2. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

    ... outcomes included the reduction of intravascular hemolysis , the change in hemoglobin (Hb) level, the withdrawal of ... overall survival. The effect of eculizumab on intravascular hemolysis was demonstrated by a reduction in lactate dehydrogenase ...

    Research Article last updated 11/02/2016 - 10:39am.

  3. Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed

    ... of this disease arise as a result of complement-mediated hemolysis in unprotected red cells, leukocytes, and platelets as well as ...

    Research Article last updated 11/28/2016 - 11:40am.

  4. Pathogenesis of paroxysmal nocturnal hemoglobinuria

    ... deficient erythrocytes increase in proportion, massive hemolysis occurs due to activated complement attack during infection. As ...

    Research Article last updated 11/02/2016 - 2:52pm.

  5. Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single-center study

    ... cell characterized by complement mediated intravascular hemolysis . There are different treatment modalities available for PNH, such ...

    Research Article last updated 11/02/2016 - 10:41am.

  6. Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis

    ... limited data on the use of eculizumab for prevention of hemolysis and its consequences in PNH patients undergoing surgery. Our ...

    Research Article last updated 11/02/2016 - 2:49pm.

  7. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

    ... outcomes included the reduction of intravascular hemolysis , the change in hemoglobin (Hb) level, the withdrawal of ... overall survival. The effect of eculizumab on intravascular hemolysis was demonstrated by a reduction in lactate dehydrogenase ...

    Research Article last updated 08/15/2016 - 9:10am.

  8. Paroxysmal Nocturnal Hemoglobinuria: The Future Of Complement-Based Therapies

    ... clinical benefit, making C3-mediated extravascular hemolysis the next challenge of PNH treatment. Indeed, a number of novel ... in clinical benefit by preventing C3-mediated extravascular hemolysis. These second-generation complement inhibitors include anti-C3 ...

    Research Article last updated 08/15/2016 - 9:11am.

  9. Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations

    ... hypertension, smooth muscle dysfunction, and chronic hemolysis . Until recently, treatment was mainly supportive with most ...

    Research Article last updated 09/13/2016 - 1:53pm.

  10. Fighting PNH While Helping PNH Patients

    ... platelet count had not been that bad… it was the hemolysis , resulting fatigue that had been the problem. For people who ...

    Patient Chronicle last updated 11/21/2016 - 12:47pm.